TITLE

luteal phase defect

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p1274
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the medical term luteal phase defect is presented. The term refers to a deficiency in either the amount or the duration of postovulatory progesterone secretion by the corpus luteum. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation of the term is also provided.
ACCESSION #
21234589

 

Related Articles

  • menacme.  // Taber's Cyclopedic Medical Dictionary;2005, p1335 

    A definition of the medical term "menacme" is presented. The term refers to the time between menarche and menopause. It can also mean the height of the menstrual activity of a woman. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation...

  • menstrual cycle.  // Taber's Cyclopedic Medical Dictionary;2005, p1340 

    A definition of the medical term "menstrual cycle" is presented. The term refers to the periodically recurrent series of changes occurring in the uterus and associated sex organs associated with menstruation and the intermenstrual period. The definition is from the "Taber's Cyclopedic Medical...

  • virilism.  // Taber's Cyclopedic Medical Dictionary;2005, p2323 

    A definition of the term "virilism" is presented. It refers to the presence or development of male secondary characteristics in a woman.

  • virilization.  // Taber's Cyclopedic Medical Dictionary;2005, p2323 

    A definition of the term "virilization" is presented. It refers to the production of masculine secondary sex changes in a woman. These characteristics include voice change, development of male-type baldness, clitoral enlargement, and increased growth of facial and body hair.

  • An update of luteal phase support in stimulated IVF cycles. H.M. Fatemi; B. Popovic-Todorovic; E. Papanikolaou; P. Donoso; P. Devroey // Human Reproduction Update;Nov2007, Vol. 13 Issue 6, p581 

    Stimulated IVF cycles are associated with luteal phase defect. In order to overcome this, different doses, durations and types of luteal phase support (LPS) have been evaluated. There is still no agreement regarding the optimal supplementation scheme. The aim of this paper is to assess the past...

  • Beneficial effects of GnRH agonist administration prior to ovarian stimulation for patients with a short follicular phase. Cedrin-Durnerin, Isabelle // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Sep2003, Vol. 7 Issue 2, p179 

    A short follicular phase is an early clinical feature of declining reproductive competence. The shortening of the follicular phase length is related to both advanced recruitment and selection of the dominant follicle secondary to an earlier and higher FSH rise during the luteal-follicular...

  • Luteal insufficiency in first trimester. Shah, Duru; Nagarajan, Nagadeepti // Indian Journal of Endocrinology & Metabolism;Jan/Feb2013, Vol. 17 Issue 1, p44 

    Luteal phase insufficiency is one of the reasons for implantation failure and has been responsible for miscarriages and unsuccessful assisted reproduction. Luteal phase defect is seen in women with polycystic ovaries, thyroid and prolactin disorder. Low progesterone environment is created...

  • Africa, sub-Saharan.  // Taber's Cyclopedic Medical Dictionary;2005, p52 

    A definition of the term Africa, sub-Saharan is presented. Sub-Saharan Africa is the large region of Africa that lies just south of the Sahara desert. Common infections in this region include malaria, meningitis, tuberculosis, and HIV. The definition is from the "Taber's Cyclopedic Medical...

  • Therapeutic Management of Luteal Insufficiency in Repeat breeder cows. Sarma, D. K.; Nath, K. C.; Bhuyan, D. // Intas Polivet;Jan-Jun2013, Vol. 14 Issue 1, p38 

    Niney Holstein Friesian crossbred repeat breeding cows devoid of ovulatory disturbances and uterine infection were tentatively diagnosed for luteal insufficiency and randomly divided into seven experimental groups. Group T1, T2 and T3 received single dose (2.5ml) of Buserelin acetate on day 0,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics